ELUT
NASDAQ
$0.93
Elutia Inc - Class A (ELUT)
Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. The company is headquartered in Silver Spring, Maryland.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $5 (+437.58%)
Market Cap
$41M
FCF 5Y CAGR
+22.70%
Profit Margin
400.2%
Beta (5Y)
0.58
Price Chart
Valuation
Market Cap$41M
P/S3.41
P/B1.79
Profitability
Total Revenue (TTM)$12M
Gross Profit (TTM)$7.02M
EBITDA-$24M
Profit Margin400.2%
Operating Margin-184.4%
EPS-$0.60
Growth & Risk
Revenue 5Y CAGR-22.89%
FCF 5Y CAGR+22.70%
Beta (5Y)0.58
Sharpe Ratio-0.65